MétaCan
Menu
Back to cohort
Record W2020026521 · doi:10.1038/clpt.2009.243

The (Possible) Impact of Comparative Effectiveness Research on Pharmaceutical Industry Decision Making

2010· review· en· W2020026521 on OpenAlexaff
Kalipso Chalkidou

Bibliographic record

VenueClinical Pharmacology & Therapeutics · 2010
Typereview
Languageen
FieldEconomics, Econometrics and Finance
TopicPharmaceutical Economics and Policy
Canadian institutionsNickel Institute
FundersNational Institutes of Health
KeywordsPharmaceutical industryComparative effectiveness researchManagement scienceBusinessMedicinePharmacologyEconomicsAlternative medicine

Abstract

fetched live from OpenAlex

Public and private payers in rich and emerging economies are becoming increasingly interested in using evidence to inform health-care resource allocation decisions. The National Institute for Health and Clinical Excellence (NICE) in the United Kingdom has been doing so on behalf of the National Health Service (NHS) for more than 10 years. To some, NICE-type entities are barriers to access and innovation. Increasingly, however, even NICE's critics appreciate that evidence-informed decision making, carried out in a fair, inclusive, and transparent way, is better than arbitrary government-imposed price cuts. For health-care systems in developed and developing countries around the world, faced with limited budgets, there may be no third option.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.275
metaresearch head score (Gemma)0.518
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesMetaresearch
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Not applicable · Consensus signal: none
GenreCandidate signal: Review · Consensus signal: Review
Teacher disagreement score0.275
Threshold uncertainty score0.894

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.2750.518
Meta-epidemiology (narrow)0.0020.001
Meta-epidemiology (broad)0.0090.007
Bibliometrics0.0070.011
Science and technology studies0.0010.009
Scholarly communication0.0090.014
Open science0.0050.004
Research integrity0.0090.008
Insufficient payload (model declined to judge)0.0170.001

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.638
GPT teacher head0.647
Teacher spread0.009 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

Study designNot applicable
Domainnot available
GenreReview

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations15
Published2010
Admission routes1
Has abstractyes

Explore more

Same venueClinical Pharmacology & TherapeuticsSame topicPharmaceutical Economics and PolicyFrench-language works237,207